The present study shows that oral chronic administration of 30 mg/kg/day Apocynin, a nontoxic herbal compound with anti-inflammatory potential acting as NADPH oxidase assembly inhibitor, improves the behavioural symptoms of the FXS in the Fmr1-KO mouse model. The gene discussed is FMR1; the disease is fragile X syndrome.